Responses
Regular and Young Investigator Award Abstracts
Cell Therapies
344 Comparative assessment of product quality attributes associated with production of chimeric antigen receptor T cells expressing scFv CD-19 and scFv IL-13Ra2 by two manufacturing platforms
Compose a Response to This Article
Other responses
No responses have been published for this article.